GB-5267

· Roswell Park Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GB-5267, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]